CAS 2088770-90-3

Brentuximab

CAS: 2088770-90-3

Brentuximab is a chimeric antibody targeting CD30 and is a naked antibody to Brentuximab vedotin.Brentuximab has antitumor activity and may be used to study

Reinheit: 94.6% (SDS-PAGE); 97.1% (SEC-HPLC) - 98.4% (SDS-PAGE); 99.2% (SEC-HPLC)

Farbe und Form: Liquid

Molekulargewicht: 145.21 kDa

Ref: TM-T76718

Brentuximab

CAS: 2088770-90-3

Antibody-drug conjugate targeting CD30; antineoplastic

Reinheit: Min. 95%

Ref: 3D-BB164045